Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Teriparatide as a Chondroregenerative Therapy in Human Osteoarthritis

NCT03072147 is registered in ClinicalTrials.gov with Christopher Ritchlin as lead sponsor.

NCT NCT03072147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03072147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Teriparatide as a Chondroregenerative Therapy in Human Osteoarthritis
Lead sponsor
Christopher Ritchlin
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2017
Completion date
September 30, 2022
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage degeneration, knee osteoarthritis